Published in J Virol on June 01, 2002
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature (2008) 5.38
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS One (2007) 1.11
Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J Virol (2008) 1.10
Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6. J Virol (2006) 0.95
Cytokine homologs of human gammaherpesviruses. J Interferon Cytokine Res (2011) 0.83
Human herpesvirus 8-encoded cytokines. Future Virol (2010) 0.77
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood (1995) 16.81
pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res (1990) 12.75
Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science (1992) 7.00
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
STATs: signal transducers and activators of transcription. Cell (1996) 6.10
Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol (1997) 5.38
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood (1996) 4.22
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood (1989) 4.17
Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science (1994) 4.07
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med (1997) 3.44
IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science (1993) 3.13
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci U S A (1990) 2.79
A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J (1995) 2.52
Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc Natl Acad Sci U S A (1995) 2.42
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood (2000) 2.31
Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med (1994) 2.13
A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00
Structure of an extracellular gp130 cytokine receptor signaling complex. Science (2001) 1.94
Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood (1998) 1.93
Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc Natl Acad Sci U S A (1994) 1.74
Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J (1993) 1.46
Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol (1999) 1.40
KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol (1999) 1.30
Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood (1998) 1.28
Crystal structure of a cytokine-binding region of gp130. EMBO J (1998) 1.23
Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J Biol Chem (1997) 1.08
Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J Immunol (1999) 1.06
Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes. Eur Cytokine Netw (1999) 1.03
Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. Clin Cancer Res (2000) 1.03
The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J Biol Chem (1998) 1.02
Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. J Biol Chem (1995) 0.99
Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Blood (1997) 0.90
The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex. Growth Factors (1999) 0.87
Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor. Eur J Biochem (1996) 0.81
Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J Virol (2008) 1.10
Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. J Mol Biol (2004) 1.05
Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol (2008) 1.02
Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6. J Virol (2006) 0.95
CDK2/cyclinA inhibitors: targeting the cyclinA recruitment site with small molecules derived from peptide leads. Bioorg Med Chem Lett (2005) 0.92
Bim nuclear translocation and inactivation by viral interferon regulatory factor. PLoS Pathog (2010) 0.89
Human herpesvirus 8 viral interleukin-6 interacts with splice variant 2 of vitamin K epoxide reductase complex subunit 1. J Virol (2011) 0.88
Galpha protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpesvirus 8 g protein-coupled receptor. J Virol (2004) 0.88
Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability. J Virol (2013) 0.87
Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry. PLoS Pathog (2012) 0.86
Determinants of secretion and intracellular localization of human herpesvirus 8 interleukin-6. J Virol (2009) 0.84
Role of ORF74-encoded viral G protein-coupled receptor in human herpesvirus 8 lytic replication. J Virol (2009) 0.84
Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res (2014) 0.84
Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor. Virology (2009) 0.83
Helix 8 of the viral chemokine receptor ORF74 directs chemokine binding. J Biol Chem (2006) 0.83